Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-22-015198
Filing Date
2022-12-21
Accepted
2022-12-21 21:20:26
Documents
2
Period of Report
2022-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-57925.html 4  
1 PRIMARY DOCUMENT marketforms-57925.xml 4 5552
2 POA DOCUMENT poa.htm EX-24 3149
  Complete submission text file 0001214659-22-015198.txt   10025
Mailing Address 3000 KENT AVENUE; SUITE A1-100 WEST LAFAYETTE IN 47906
Business Address
Meek David D. (Reporting) CIK: 0001555337 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 221479609

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations